CorFlow Therapeutics
Baar
About CorFlow Therapeutics
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complication rates in these patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $66.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2024)
- Website: corflow.com
- Phone: +41 41 544 55 55
Industries & Categories
Biotechnology, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/corflow-therapeutics-47071 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.